טוען...
Inhibition of pathological brain angiogenesis through systemic delivery of AAV vector expressing soluble FLT1
The soluble vascular endothelial growth factor (VEGF) receptor 1 (sFLT1) has been tested in both animals and humans for anti-angiogenic therapies, e.g., age-related macular degeneration. We hypothesized that adeno-associated viral vector (AAV)-mediated sFLT1 expression could be used to inhibit abnor...
שמור ב:
| הוצא לאור ב: | Gene Ther |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4636448/ https://ncbi.nlm.nih.gov/pubmed/26090874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gt.2015.57 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|